Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Veerhealth Care Ltd. exhibits weak financial performance compared to its peers, with no revenue or earnings growth, and a high PE ratio suggesting overvaluation. In contrast, Sun Pharmaceutical Industries and Cipla Ltd. are strong overall performers with solid profitability, growth, and attractive valuation metrics, making them the sector leaders.
Highest revenue growth YoY (8.42%) and strong profitability indicators with ROE at 16.13%.
Solid revenue growth (13.28% YoY), excellent ROE (16.63%), and low PE ratio (23.73) making it attractive.